132 related articles for article (PubMed ID: 16394444)
1. Lichenoid eruption due to imatinib.
Prabhash K; Doval DC
Indian J Dermatol Venereol Leprol; 2005; 71(4):287-8. PubMed ID: 16394444
[No Abstract] [Full Text] [Related]
2. Imatinib for chronic myeloid leukaemia: a NICE mess.
Lim D; Muir J
Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
[No Abstract] [Full Text] [Related]
3. Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate.
Kagimoto Y; Mizuashi M; Kikuchi K; Aiba S
Int J Dermatol; 2014 Mar; 53(3):e161-2. PubMed ID: 23786260
[No Abstract] [Full Text] [Related]
4. Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia.
Machaczka M; Gossart M
Pol Arch Med Wewn; 2013; 123(5):251-2. PubMed ID: 23722191
[No Abstract] [Full Text] [Related]
5. Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate.
Lau YM; Lam YK; Leung KH; Lin SY
Hong Kong Med J; 2014 Oct; 20(5):464.e2. PubMed ID: 25307080
[No Abstract] [Full Text] [Related]
6. Cutaneous lichenoid eruption caused by imatinib mesylate in a Japanese patient with chronic myeloid leukaemia.
Kawakami T; Kawanabe T; Soma Y
Acta Derm Venereol; 2009; 89(3):325-6. PubMed ID: 19479144
[No Abstract] [Full Text] [Related]
7. Oral lichenoid reaction to imatinib (STI 571, Gleevec).
Lim DS; Muir J
Dermatology; 2002; 205(2):169-71. PubMed ID: 12218235
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Lichenoid dermatitis associated with imatinib mesylate.
Chan CY; Browning J; Smith-Zagone MJ; Martinelli PT; Hsu S
Dermatol Online J; 2007 May; 13(2):29. PubMed ID: 17498448
[No Abstract] [Full Text] [Related]
9. Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases.
Pascual JC; Matarredona J; Miralles J; Conesa V; Borras-Blasco J
Int J Dermatol; 2006 Dec; 45(12):1471-3. PubMed ID: 17184272
[No Abstract] [Full Text] [Related]
10. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
Dalmau J; Peramiquel L; Puig L; Fernández-Figueras MT; Roé E; Alomar A
Br J Dermatol; 2006 Jun; 154(6):1213-6. PubMed ID: 16704665
[No Abstract] [Full Text] [Related]
11. Lichenoid drug eruption related to imatinib: report of a new case and review of the literature.
Sendagorta E; Herranz P; Feito M; Ramírez P; Feltes R; Floristán U; Mariño-Enriquez A; Casado M
Clin Exp Dermatol; 2009 Oct; 34(7):e315-6. PubMed ID: 19456782
[No Abstract] [Full Text] [Related]
12. Oral lichenoid eruption associated with imatinib treatment.
Gómez Fernández C; Sendagorta Cudós E; Casado Verrier B; Feito Rodríguez M; Suárez Aguado J; Vidaurrázaga Díaz de Arcaya C
Eur J Dermatol; 2010; 20(1):127-8. PubMed ID: 19825526
[No Abstract] [Full Text] [Related]
13. [Lichenoid cutaneous reaction to imatinib].
Roux C; Boisseau-Garsaud AM; Saint-Cyr I; Hélénon R; Quist D; Delaunay C
Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):571-3. PubMed ID: 15318140
[TBL] [Abstract][Full Text] [Related]
14. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
Rousselot P; Larghero J; Raffoux E; Calvo F; Tulliez M; Giraudier S; Rybojad M
Br J Haematol; 2003 Mar; 120(6):1091-2. PubMed ID: 12648085
[No Abstract] [Full Text] [Related]
15. Lichenoid eruption to STI 571.
Lim D; Muir J
Am J Hematol; 2002 Jun; 70(2):179. PubMed ID: 12111794
[No Abstract] [Full Text] [Related]
16. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
Kuraishi N; Nagai Y; Hasegawa M; Ishikawa O
Acta Derm Venereol; 2010; 90(1):73-6. PubMed ID: 20107730
[TBL] [Abstract][Full Text] [Related]
17. Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
Pavithran K; Thomas M
Indian J Dermatol Venereol Leprol; 2005; 71(4):288-9. PubMed ID: 16394445
[No Abstract] [Full Text] [Related]
18. Precipitation of porphyria cutanea tarda by imatinib mesylate?
Ho AY; Deacon A; Osborne G; Mufti GJ
Br J Haematol; 2003 Apr; 121(2):375. PubMed ID: 12694262
[No Abstract] [Full Text] [Related]
19. Imatinib mesylate induced immune thrombocytopenia.
Rajappa S; Varadpande L; Paul TR; Digumarti R
Leuk Lymphoma; 2007 Nov; 48(11):2261-3. PubMed ID: 17926182
[No Abstract] [Full Text] [Related]
20. Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
Yamazaki R; Okamoto S; Chen CK; Tada S; Saito H; Shibata R; Sakamoto M; Mori T; Ikeda Y
Leuk Lymphoma; 2006 Jul; 47(7):1427-30. PubMed ID: 16923586
[No Abstract] [Full Text] [Related]
[Next] [New Search]